By application, the US Radiotherapy market is segmented into external beam radiotherapy (EBRT) applications and internal beam radiotherapy (IBRT) applications. The external beam radiotherapy (EBRT ...

Patients in the EBRT study arm were treated with a radiation dose of either 68 Gy (n = 58) a low dose by today's standards, or ≥70 Gy (n = 56); elective nodal radiotherapy was not used.

In comparison, recurrent glioblastoma patients treated with EBRT alone have a reported median survival of 9.9 months from treatment. Eight patients were included in the study with adaptive dosing ...